Clinical trial
Predictive Factors of Disease-free Survival After Complete Pathological Response to Neoadjuvant Radiotherapy in Rectal Adenocarcinoma
NCT03601689 is registered in ClinicalTrials.gov with Moroccan Society of Surgery as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Predictive Factors of Disease-free Survival After Complete Pathological Response to Neoadjuvant Radiotherapy in Rectal Adenocarcinoma
- Lead sponsor
- Moroccan Society of Surgery
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2005
- Completion date
- March 31, 2016
- Enrollment
- 84 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.